Abstract
Impaired motor vigor is a defining characteristic of Parkinson’s disease (PD), yet the underlying brain mechanisms governing motor vigor (MV) remain unclear. Recent studies have suggested beta-gamma Phase-Amplitude Coupling (PAC) derived from the resting-state electroencephalogram (EEG) is a potential biomarker for PD that is modulated by Deep Brain Stimulation (DBS) and L-dopa treatment. Specifically, PAC has been suggested to be a marker of transitions between motor movements, as opposed to encoding the vigor of the current movement. Here, we comprehensively investigate the potential of various PAC interactions—across different frequency pairs—beyond the linear approaches typically employed to predict MV during motor tasks in PD and study the effects of dopaminergic medication and non-invasive Galvanic Vestibular Stimulation (GVS). We recorded EEG data from 20 PD patients and 22 healthy controls executing a simple, overlearned handgrip task. Subjects were tested on and off L-dopa medication and with and without GVS (multi-sine either 50-100Hz, 100-150Hz). In a preliminary linear (LASSO-based) analysis comparing various PACs and a broad range of commonly used EEG features, PAC features were found to be crucial for predicting MV approximately equally in PD and HC. Initial findings from the linear analysis showed PAC as a significant indicator for MV in both groups, although with variability in cross-validation that implied a complex, non-linear relationship between PAC and MV. To extensively investigate the PAC-MV relation, we used a deep convolutional neural network (PACNET)—developed based on pre-trained VGG-16 architecture—to estimate MV from PAC values. In both PD and HCs, delta-beta, theta-, alpha-, and beta-gamma PACs were important for MV prediction. In PD subjects, GVS affected delta-beta, theta-gamma-, and beta-gamma PACs role in MV prediction, which was sensitive to different GVS stimulation parameters. These PACs were also relevant for PD patients’ MV prediction after L-dopa medication. This study supports the hypothesis that EEG PAC across multiple frequency pairs, not just beta-gamma, predicts MV and not just motor transitions and can be a biomarker for assessing the impact of electrical stimulation and dopaminergic medication in PD. Our results suggest that PAC is involved in MV, in addition to a range of previously reported cognitive processes, including working and long-term memory, attention, language, and fluid intelligence. Non-linear approaches appear important for examining EEG PAC and behavior relations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by resources made available through the Dynamic Brain Circuits cluster and the NeuroImaging and NeuroComputation Centre at the UBC Djavad Mowafaghian Centre for Brain Health (RRID SCR_019086). MJM was supported by the John Nichol Chair in Parkinson‱s Research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of the Clinical Research Ethics Board at the University of British Columbia gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Equal contributions
_New section "Author Contributions" is added to clarify authors' role and contribution. _Section Code/Data Availability updated to reflect data availability statement and working URL of the codes. _The entire manuscript has been reformatted to adhere to APA 7th Edition guidelines. _Orchid ID is added for one of the authors _Supplemental files updated.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
